Skip to content

CERELO: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

CERELO

BE 0883.004.361
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€13,923
2024 · €43,711-€57,634
Equity
€637,233
2024 · €652,157-€14,925
Cash
€712,493
2024 · €702,017+€10,476
Balance sheet total
€1.1m
2024 · €1.1m-€12,980

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets -€24,913

    down €24,913 (-6.5%), from €383,389 to €358,476

Equity and liabilities
  • Profit (loss) carried forward -€13,923

    down €13,923 (-3.0%), from €470,142 to €456,219

Income statement
  • Financial income -€77,766

    down €77,766 (-87.1%), from €89,326 to €11,560

  • Taxes -€20,065

    no longer reported in 2025 (was €20,065)

  • Gross operating margin +€319

    up €319 (+17.9%), from €1,778 to €2,096

  • Other operating charges +€251

    up €251 (+10.6%), from €2,379 to €2,630

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €43,711
Gross operating margin +€319
Other operating charges -€251
Financial income -€77,766
Taxes +€20,065
Result 2025 -€13,923
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€11,478
Investment €0
Financing -€1,002
Cash 2024 €702,017
Net result for the year -€13,923
Depreciation +€24,913
Receivables within one year +€1,865
Deferred charges and accrued income -€3,322
Trade debts +€1,944
Contributions, distributions and other -€1,002
Cash 2025 €712,493
brings cash intakes cash out
Every line side by side 38 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,102,333 €1,089,352 -€12,980 -1.2%
Fixed assets 21/28 €383,389 €358,476 -€24,913 -6.5%
Tangible fixed assets 22/27 €383,389 €358,476 -€24,913 -6.5%
Land and buildings 22 €383,389 €358,476 -€24,913 -6.5%
Current assets 29/58 €718,944 €730,877 +€11,933 +1.7%
Amounts receivable within one year 40/41 €16,341 €14,476 -€1,865 -11.4%
Trade receivables 40 - €12,821 +€12,821
Other amounts receivable 41 €16,341 €1,655 -€14,686 -89.9%
Cash at bank and in hand 54/58 €702,017 €712,493 +€10,476 +1.5%
Deferred charges and accrued income 490/1 €586 €3,908 +€3,322 +567%
Total equity and liabilities 10/49 €1,102,333 €1,089,352 -€12,980 -1.2%
Equity 10/15 €652,157 €637,233 -€14,925 -2.3%
Contributions 10/11 €63,000 €63,000 = 0.0%
Capital 10 €63,000 €63,000 = 0.0%
Issued capital 100 €63,000 €63,000 = 0.0%
Reserves 13 €100,949 €100,949 = 0.0%
Non-distributable reserves 130/1 €6,300 €6,300 = 0.0%
Legal reserve 130 €6,300 €6,300 = 0.0%
Distributable reserves 133 €94,649 €94,649 = 0.0%
Profit (loss) carried forward 14 €470,142 €456,219 -€13,923 -3.0%
Investment grants 15 €18,067 €17,065 -€1,002 -5.5%
Amounts payable 17/49 €450,175 €452,120 +€1,944 +0.4%
Amounts payable within one year 42/48 €450,175 €452,120 +€1,944 +0.4%
Trade debts 44 €175 €2,120 +€1,944 +1,108%
Suppliers 440/4 €175 €2,120 +€1,944 +1,108%
Other amounts payable 47/48 €450,000 €450,000 = 0.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €24,913 €24,913 = 0.0%
Other operating charges 640/8 €2,379 €2,630 +€251 +10.6%
Gross operating margin 9900 €1,778 €2,096 +€319 +17.9%
Operating profit (loss) 9901 -€25,514 -€25,447 +€67 +0.3%
Financial income 75/76B €89,326 €11,560 -€77,766 -87.1%
Recurring financial income 75 €89,326 €11,560 -€77,766 -87.1%
Financial charges 65/66B €36 €36 = 0.0%
Recurring financial charges 65 €36 €36 = 0.0%
Profit (loss) for the period before taxes 9903 €63,776 -€13,923 -€77,699
Income taxes 67/77 €20,065 - -€20,065
Profit (loss) for the period 9904 €43,711 -€13,923 -€57,634
Profit (loss) for the period to be appropriated 9905 €43,711 -€13,923 -€57,634

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.